Allen P D, Schmidt T A, Marsh J D, Kjeldsen K
Department of Anesthesia, Brigham and Women's Hospital, Boston, Massachusetts.
Basic Res Cardiol. 1992;87 Suppl 1:87-94. doi: 10.1007/978-3-642-72474-9_7.
The expression of the Na,K-ATPase was studied in both normal and failing human myocardium which was collected within 5 min of cardiac explantation in preparation for orthotopic transplantation or at the time of organ harvest. Abundance of mRNA for all three catalytic alpha subunits of the Na,K-ATPase was analyzed in samples from patients with end-stage heart failure due to either ischemic or dilated cardiomyopathy, as well as from normal controls. Vanadate facilitated 3H-ouabain binding before and after a Digibind wash was analyzed on tissue from a subset of these patients. mRNA analysis demonstrated that all three catalytic Na,K-ATPase alpha subunits were expressed in human heart and that there was no evidence for change in relative expression or abundance induced by disease. The specific digitalis receptor concentration was 760 +/- 58 and 614 +/- 47 pmol/g wet weight in the samples from normal and failing hearts, respectively (p = NS). From these studies it can be concluded that, whereas there is a tendency for a decrease in the number of ouabain receptors in heart failure, there is no significant alteration in the expression of Na,K-ATPase message or protein caused by chronic heart failure.
在准备原位移植时于心脏离体后5分钟内收集的正常和衰竭的人心肌中,以及在器官获取时收集的心肌中,研究了钠钾ATP酶的表达。分析了因缺血性或扩张型心肌病导致的终末期心力衰竭患者以及正常对照者样本中钠钾ATP酶所有三个催化性α亚基的mRNA丰度。对这些患者亚组的组织进行分析,研究了在进行地高辛抗体洗脱前后钒酸盐对3H-哇巴因结合的促进作用。mRNA分析表明,钠钾ATP酶的所有三个催化性α亚基均在人心脏中表达,且没有证据表明疾病会导致相对表达或丰度发生变化。正常心脏和衰竭心脏样本中的特异性洋地黄受体浓度分别为760±58和614±47 pmol/g湿重(p =无显著性差异)。从这些研究可以得出结论,虽然心力衰竭时哇巴因受体数量有减少的趋势,但慢性心力衰竭不会导致钠钾ATP酶的信息或蛋白表达发生显著改变。